D-1542-2014 Class II Terminated
FDA drug recall D-1542-2014 was initiated by Baxter Healthcare Corp on Aug 4, 2014 and is designated Class II. Reason for recall: Presence of Particulate Matter: identification of particulates in a retention sample that have been identified as a mixture of the amino acid leucine and inorganic material (containing iron, silicone… The recall status is terminated (terminated Jun 10, 2015). Affected quantity: 6,204 bags.
Recall Details
- Product Type
- Drugs
- Report Date
- Aug 27, 2014
- Initiation Date
- Aug 4, 2014
- Termination Date
- Jun 10, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 6,204 bags
Product Description
ProSol - sulfite-free (Amino Acid) Injection, 20%, 2000 mL VIAFLEX container bag, Rx only, Baxter Healthcare Corporation, Clinitec Nutrition Division, Deerfield, IL 60015 USA, Product Code 2B6186, NDC 0338-0499-06.
Reason for Recall
Presence of Particulate Matter: identification of particulates in a retention sample that have been identified as a mixture of the amino acid leucine and inorganic material (containing iron, silicone and chlorine).
Distribution Pattern
Nationwide
Code Information
Lot #: P306225, Exp 08/14
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1542-2014
- openFDA file date
- Oct 27, 2026
- Loaded by RegDataLab
- Oct 29, 2026